Clinical Trial Update: Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

View source ↗

Summary

A Mayo Clinic-sponsored trial evaluates the acceptability of using DNA markers in vaginal fluid to detect endometrial cancer; the study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Endometrial Carcinoma | Status: NOT_YET_RECRUITING